Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Anthera Seeks to Tap Heart Attack Market by Blocking Inflammation
Motley Fool
Tuesday, November 16, 2010 - 1:22pm
tags:
Anthera, heart attacks
Cost-Cutting at Pfizer: Layoffs and Shared Hotel Rooms Up the Misery
BNET Pharma
Tuesday, November 16, 2010 - 12:40pm
tags:
layoffs, Pfizer
Dead in the Water? Glaxo’s Fish Oil Pill and A-Fib
Seeking Alpha
Tuesday, November 16, 2010 - 12:39pm
tags:
GSK, fish oil, atrial fibrillation, Lovaza
Are Shorts Watching This Number at Qiagen?
Motley Fool
Tuesday, November 16, 2010 - 12:05pm
tags:
Qiagen
Pharmacyclics: Showing Promise
Seeking Alpha
Tuesday, November 16, 2010 - 12:03pm
tags:
Pharmacyclics, Pfizer, Protalix BioTherapeutics, Sanofi, Genzyme
Endo Plans Debt After Most Sales in Six Weeks: New Issue Alert
Bloomberg
Tuesday, November 16, 2010 - 12:00pm
tags:
Endo
Doctors say blood-clot drug race too close to call
Reuters
Tuesday, November 16, 2010 - 11:59am
tags:
blood thinners, Pradaxa, Xarelto, Bayer, JNJ, Boehringer Ingelheim
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Bloomberg
Tuesday, November 16, 2010 - 11:57am
tags:
Eisai, Aricept, breast cancer, Eribulin
Human Genome: FDA Panel Live Blog
TheStreet.com
Tuesday, November 16, 2010 - 11:56am
tags:
Human Genome Sciences, FDA, advisory panels, Benlysta
Bristol-Myers Partner Otsuka Wins Abilify Ruling
Bloomberg
Tuesday, November 16, 2010 - 9:36am
tags:
Otsuka, Bristol-Myers Squibb, Abilify, patents, Teva Pharmaceuticals, Sun Pharma, Sandoz, Apotex
Johnson & Johnson Hid Antibiotic’s Risk, Lawyer Says
Bloomberg
Tuesday, November 16, 2010 - 9:33am
tags:
JNJ, antibiotics, Levaquin
Novartis closes in on growth formula
FT.com
Monday, November 15, 2010 - 8:51pm
tags:
Novartis, M&A, Alcon
Big Pharma’s Comeback?
Forbes
Monday, November 15, 2010 - 8:50pm
tags:
Big Pharma, JNJ, Xarelto, Bayer
Loss Widens at Isis Pharma
Yahoo/Zacks.com
Monday, November 15, 2010 - 8:48pm
tags:
earnings, Isis Pharmaceuticals
A Mega-Blockbuster Showdown
Motley Fool
Monday, November 15, 2010 - 6:28pm
tags:
Boehringer Ingelheim, Pradaxa, Bayer, Xarelto, JNJ
Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer
Bloomberg
Monday, November 15, 2010 - 6:26pm
tags:
Eisai, breast cancer, FDA, Eribulin
No White Knight for Genzyme
Minyanville
Monday, November 15, 2010 - 6:25pm
tags:
Sanofi, Takeda, Genzyme, M&A
Report: Termeer's value hunt yields buyout interest
Fierce Pharma
Monday, November 15, 2010 - 12:02pm
tags:
Henri Termeer, Genzyme, Takeda, Sanofi
Merck set with India strategy; talks on for partnerships
Live Mint, India
Monday, November 15, 2010 - 11:20am
tags:
Merck, India
Are These Biotechs Creating Value?
Motley Fool
Monday, November 15, 2010 - 11:18am
tags:
Seattle Genetics, Human Genome Sciences, Gilead Sciences, Celgene, biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.